Does acetylsalicylic acid reduce the mortality of patients admitted to an Intensive Care Unit
Phase 1
- Conditions
- medical patients admitted to an intensive care unitTherapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
- Registration Number
- EUCTR2012-002235-29-AT
- Lead Sponsor
- Medizinische Universität Wien - Universitätsklinik für klinische Pharmakologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
over 18 years
admittance to ICU
ASA naive patients
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 230
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 230
Exclusion Criteria
Known allergy or intolerance to ASA
Recent surgery or planned surgery
Active bleeding
Known coagulation disorders
Discretion of the physician
Terminal illness (anticipated life expectancy <3months; e.g. due to cancer)
recent ulcera
recent gastrointestinal bleeding
pregnancy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method